If you have ever been diagnosed with colorectal cancer, join a nationwide movement of patients to contribute your samples, your medical records, and your voice to colorectal cancer research. Together, we can speed the development of future therapies.
History and Milestones
Count Me In (CMI) began with discussions between Emerson Collective and the Broad Institute of MIT and Harvard in 2013. Since the launch of the first project in metastatic breast cancer in late 2015, thousands of individuals living with cancer from around the United States and Canada have said “Count Me In” to partnering with researchers and sharing their experiences